In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of PDS Biotechnology Corporation (NASDAQ: PDSB) closed at $1.58 in the last session, down -3.07% from day before closing price of $1.63. In other words, the price has decreased by -$3.07 from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
We take a closer look at PDSB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.33. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $10.
On June 28, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
H.C. Wainwright Upgraded its Neutral to Buy on November 10, 2020, while the target price for the stock was maintained at $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Freitag Gregory Gene bought 15,060 shares for $1.66 per share. The transaction valued at 25,000 led to the insider holds 61,213 shares of the business.
Glover Stephen C. bought 15,061 shares of PDSB for $25,001 on Feb 28 ’25. The Director now owns 78,851 shares after completing the transaction at $1.66 per share.
Stock Price History:
Over the past 52 weeks, PDSB has reached a high of $4.42, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 28.27%, while the 200-Day Moving Average is calculated to be -25.53%.
Shares Statistics:
A total of 45.45M shares are outstanding, with a floating share count of 43.98M. Insiders hold about 3.78% of the company’s shares, while institutions hold 17.85% stake in the company.
